Alfresa Group operates in the healthcare industry, supporting pharmaceutical supply chains and meeting a wide range of medical needs through ethical pharmaceutical wholesaling, self-medication products wholesaling, manufacturing, and medical-related businesses.

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.

2784

COM:ALFRESA

Alfresa Group

Last Close

2,274.50

25/11 06:45

Market Cap

423.82B

Beta: -

Volume Today

823.70K

Avg: -

Analysis Not Available